Switzerland: New Technology

AI agents no longer merely recommend purchases — they are beginning to select merchants, conclude transactions and pay, within mandates their users define in advance. For Swiss banks and fintechs, this shifts the legal question from whether an institution may deploy an autonomous agent to whether a customer can validly authorise today a payment whose amount, counterparty and timing will only be determined tomorrow. The payment mandate, not the individual payment instruction, becomes the decisive legal control point.

Louis Burrus is a legal professional featured in the lawyer directory at SW Legal. His profile provides access to his professional background, areas of practice, and contact information for those seeking legal representation or consultation.

Künstliche Intelligenz (KI) wird zunehmend bei unterneh mensinternen Untersuchungen eingesetzt. KI beschleu nigt die Dokumentenanalyse, erkennt Muster in grossen Datenmengen, extrahiert relevante Informationen und erstellt strukturierte Gesprächsprotokolle. Diese Vorteile sind insbesondere bei komplexen, grenzüberschreitenden Untersuchungen mit umfangreichen Datenbeständen von erheblicher Bedeutung.

Switzerland's Consumer Products & Retail sectors face profound structural challenges from changing consumer behaviors, new technologies, and environmental pressures.

Anne Laure Bandle's column "Droit dans l'Art" explores the evolving legal landscape of the art world, from Switzerland's tightened cultural property regulations to the challenges posed by AI-generated artworks.

Switzerland’s sector-specific, technology-neutral approach to AI – from FINMA Guidance 08/2024 to the Council of Europe AI Convention – mapped against the operational reality of Swiss FinTech.

AI-enabled wearable medical devices are reshaping healthcare by enabling continuous physiological monitoring, real-time clinical insights and increasingly personalized interventions.

The EU Artificial Intelligence Act (AI Act) introduces a risk-based regulatory framework that will significantly impact medical technology (MedTech) organizations operating in Europe and beyond...

In software contracts, the intellectual property (IP) clause often determines whether a deal thrives or becomes a source of disputes.